Related Experiment Video

Updated: Jun 17, 2026

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Reprogramming into pancreatic endocrine cells based on developmental cues

Simon Kordowich1, Ahmed Mansouri, Patrick Collombat

  • 1Max-Planck Institute for Biophysical Chemistry, Department of Molecular Cell Biology, Am Fassberg, D-37077 Göttingen, Germany.

Molecular and Cellular Endocrinology
|December 23, 2009
PubMed

Insights

Type 1 diabetes requires new treatments. Researchers are exploring stem cell differentiation and cell transdifferentiation to generate insulin-producing beta cells, needing a deeper understanding of molecular mechanisms for successful regeneration.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Increasing prevalence of type 1 diabetes necessitates alternative therapeutic strategies.
  • Current treatments for type 1 diabetes face complications, driving research into beta-cell replacement.
  • Beta-cell deficiency is a hallmark of type 1 diabetes, requiring novel approaches for restoration.

Purpose of the Study:

  • To review key molecular factors in endocrine cell lineage differentiation during pancreas development.
  • To explore the potential of stem/progenitor cell differentiation and cell transdifferentiation for generating insulin-producing beta cells.
  • To highlight beta-cell regeneration and its underlying determinants.

Main Methods:

  • Literature review of molecular mechanisms in pancreas morphogenesis.
  • Analysis of factors involved in endocrine cell differentiation.
  • Examination of beta-cell regeneration strategies and determinants.

Main Results:

  • Identified key factors and their interplay in endocrine cell lineage development.
  • Summarized current strategies for generating insulin-producing beta cells.
  • Discussed the potential and challenges of cell-based therapies for type 1 diabetes.

Conclusions:

  • A comprehensive understanding of molecular mechanisms is crucial for successful beta-cell generation.
  • Stem cell differentiation and cell transdifferentiation hold promise for type 1 diabetes therapy.
  • Further research into beta-cell regeneration determinants is essential for clinical application.

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

Related Concept Videos

Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...